Literature DB >> 30902138

PRE-binding protein of Plasmodium falciparum is a potential candidate for vaccine design and development: An in silico evaluation of the hypothesis.

Bijara Devi Sanasam1, Sanjeev Kumar2.   

Abstract

Immunity to Plasmodium falciparum is contributed by many known and unknown factors. Lack of effective vaccine and rise in drug-resistant Plasmodium parasites leads to the major challenge in controlling the parasite. Determination of surface or secreted proteins which are essential for the survival of the pathogen is a very important step in finding potential vaccine candidates. Despite the discovery of several vaccine candidates against Plasmodium over the last decades, an effective vaccine is not available. The present study hypothesized that the PRE-binding protein (PREBP) could be a potential vaccine candidate against malaria pathogenesis. PREBP is highly conserved among the class Aconoidasida and exhibit high antigenicity and accessibility as a secretory protein. The present hypothesis was tested by employing in-silico translational genomics wherein the antigenicity, localization and the conservancy were determined.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Malaria; PRE-binding proteins (PREBP); Plasmodium falciparum; Vaccine candidate

Mesh:

Substances:

Year:  2019        PMID: 30902138     DOI: 10.1016/j.mehy.2019.01.006

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative.

Authors:  Kitiya Rujimongkon; Mathirut Mungthin; Jumreang Tummatorn; Sumate Ampawong; Poom Adisakwattana; Usa Boonyuen; Onrapak Reamtong
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

2.  A cutting-edge immunoinformatics approach for design of multi-epitope oral vaccine against dreadful human malaria.

Authors:  Manisha Pritam; Garima Singh; Suchit Swaroop; Akhilesh Kumar Singh; Brijesh Pandey; Satarudra Prakash Singh
Journal:  Int J Biol Macromol       Date:  2020-04-29       Impact factor: 6.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.